Cargando…
Industry incentives and antibiotic resistance: an introduction to the antibiotic susceptibility bonus
The scarcity of novel antibiotic compounds in a time of increasing resistance rates has begun to ring alarm bells at the highest echelons of government. Large new financial incentives to accelerate antibiotic research and development, such as market entry rewards (MERs), are being considered. Howeve...
Autores principales: | Morel, Chantal M., Lindahl, Olof, Harbarth, Stephan, de Kraker, Marlieke E. A., Edwards, Suzanne, Hollis, Aidan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292800/ https://www.ncbi.nlm.nih.gov/pubmed/32203126 http://dx.doi.org/10.1038/s41429-020-0300-y |
Ejemplares similares
-
Surveillance of Resistance to New Antibiotics in an Era of Limited Treatment Options
por: Morel, Chantal M., et al.
Publicado: (2021) -
Combatting Antibiotic Resistance Together: How Can We Enlist the Help of Industry?
por: Edwards, Suzanne E., et al.
Publicado: (2018) -
Performance Pay in Hospitals: An Experiment on Bonus–Malus Incentives
por: Kairies-Schwarz, Nadja, et al.
Publicado: (2020) -
Linking Sustainable Use Policies to Novel Economic Incentives to Stimulate Antibiotic Research and Development
por: Theuretzbacher, Ursula, et al.
Publicado: (2017) -
Study protocol for a multicentre, cluster randomised, superiority trial evaluating the impact of computerised decision support, audit and feedback on antibiotic use: the COMPuterized Antibiotic Stewardship Study (COMPASS)
por: Catho, Gaud, et al.
Publicado: (2018)